I am borrowing this picture above that was posted on the internet. I've noticed that the US Patent # posted on the picture is not the same Patent # I am sharing with you here. I have not yet researched for the Patent # mentioned in the picture but I do have information below on Patent # 6630507
US Patent 6630507 -
Cannabinoids as antioxidants and neuroprotectants
The US government holds a patent on medical hemp unlike many of us were led to believe. Many of us were under the impression that it was a major drug company which held the patent.
We confirmed it at the patent office, that the United States Government, who has imprisoned and caused the untimely deaths of many over the issue of marijuana/hemp, holds a patent on medical hemp. They made it illegal for us to study and use one of the most effective medicines on the planet while they took their time getting a patent on it.
The Department of Health and Human Services hold the patent 6630507, Cannabinoids as antioxidants and neuroprotectants, a medical hemp patent.
Below is the text of the patent, US Patent No 6630507,
US Patent Issued on October 7, 2003
Abstract
Cannabinoids
have been found to have antioxidant properties, unrelated to NMDA
receptor antagonism. This new found property makes cannabinoids useful in
the treatment and prophylaxis of wide variety of oxidation associated
diseases, such as ischemic, age-related, inflammatory and autoimmune
diseases.
The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in theatreatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, HIV and dementia.
Nonpsychoactive cannabinoids, such as cannabid oil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.
A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula(I) where in the R group is independently selected from the group consisting of H, CH3, and COCH3. ##STR1##
The cannabinoids are found to have particular application as neuroprotectants, for example in limiting neurological damage following ischemic insults, such as stroke and trauma, or in theatreatment of neurodegenerative diseases, such as Alzheimer's disease, Parkinson's disease, HIV and dementia.
Nonpsychoactive cannabinoids, such as cannabid oil, are particularly advantageous to use because they avoid toxicity that is encountered with psychoactive cannabinoids at high doses useful in the method of the present invention.
A particular disclosed class of cannabinoids useful as neuroprotective antioxidants is formula(I) where in the R group is independently selected from the group consisting of H, CH3, and COCH3. ##STR1##
Inventor(s) Hampson, Aidan J.
Axelrod, Julius
Grimaldi, Maurizio
Assignee The United States of America as represented by the Department of Health and Human Services
ApplicationNo. 09/674028 filed on 02/02/2001
Current US Class 514/454 Tricyclo ring system having the hetero ring as one of the cyclos
Field of Search 514/454 Tricyclo ring system having the hetero ring as one of the cyclos
ExaminersPrimary: Weddington, Kevin E.
Attorney, Agent or Firm Klarquist Sparkman, LLP
US Patent References 2304669, 4876276, (3S-4S)-7-hydroxy-Ɗ6 -tetrahydrocannabinols Issued on: 10/24/1989 Inventor: Mechoulam, et al.5227537, Method for the production of 6,12-dihydro-6-hydroxy-cannabidiol and the use thereof for the production of trans-delta-9-tetrahydrocannabinol Issued on: 07/13/1993 Inventor: Stoss, et al.5284867, NMDA-blocking pharmaceutical compositions Issued on: 02/08/1994 Inventor: Kloog, et al.5434295, Neuroprotective pharmaceutical compositions of 4-phenylpinene derivatives and certain novel 4-phenylpinene compounds Issued on: 07/18/1995 Inventor: Mechoulam, et al.5462946, Nitroxides as protectors against oxidative stress Issued on: 10/31/1995 Inventor: Mitchell, et al.5512270, Method of inhibiting oxidants using alkylaryl polyether alcohol polymers Issued on: 04/30/1996 Inventor: Ghio, et al.5521215, NMDA-blocking pharmaceuticals Issued on: 05/28/1996 Inventor: Mechoulam, et al.5538993, Certain tetrahydrocannabinol-7-oic acid derivatives Issued on: 07/23/1996 Inventor: Mechoulam, et al.5635530, (3S,4S)-delta-6-tetrahydrocannabinol-7-oic acids and derivatives thereof, processors for their preparation and pharmaceutical compositions containing them Issued on: 06/03/1997 Inventor: Mechoulam, et al.5696109, Synthetic catalytic free radical scavengers useful as antioxidants for prevention and therapy of disease Issued on: 12/09/1997 Inventor: Malfroy-Camine, et al.6410588 Use of cannabinoids as anti-inflammatory agents Issued on: 06/25/2002 Inventor: Feldmann, et al.International classA61K 31/35 (20060101)
Other References
Windholz et al., The Merck Index, Tenth Edition (1983) p. 241, abstract No. 1723.
Mechoulam et al., "A Total Synthesis of d1-Ɗ1 -Tetrahydrocannabinol, the Active Constituent of Hashish1," Journal of the American Chemical Society, 87:14:3273-3275 (1965)
Mechoulam et al., "Chemical Basis of Hashish Activity," Science, 18:611-612 (1970)
Ottersen et al., "The Crystal and Molecular Structure of Cannabidiol," Acta Chem. Scand. B 31, 9:807-812 (1977)
Cunha et al., "Chronic Administration of Cannabidiol to Healthy Volunteers and Epileptic Patients1," Pharmacology, 21:175-185 (1980)
Consroe et al., "Acute and Chronic Antiepileptic Drug Effects in Audiogenic Seizure-Susceptible Rats," Experimental Neurology, Academic Press Inc., 70:626-637 (1980)
Turkanis et al., "Electrophysiologic Properties of the Cannabinoids," J. Clin. Pharmacol., 21:449S-463S (1981)
Carlini et al., "Hypnotic and Antielpileptic Effects of Cannabidiol," J. Clin. Pharmacol., 21:417S-427S (1981)
Karler et al., "The Cannabinoids as Potential Antiepileptics," J. Clin. Pharmacol., 21:437S-448S (1981)
Consroe et al., "Antiepileptic Potential of Cannabidiol Analgos," J. Clin. Pharmacol., 21:428S-436S (1981)
Colasanti et al., "Ocular Hypotension, Ocular Toxicity,a nd Neurotoxicity in Response to Marihuana Extract and Cannabidiol," Gen Pharm., Pergamon Press Ltd., 15(6):479-484 (1984)
Colasanti et al., "Intraocular Pressure, Ocular Toxicity and Neurotoxicity after Administration of Cannabinol or Cannabigerol," Exp. Eye Res., Academic Press Inc., 39:251-259 (1984)
Volfe et al., "Cannabinoids Block Release of Serotonin from Platelets Induced by Plasma frm Migraine Patients," Int. J. Clin. Pharm. Res., Bioscience Ediprint Inc., 4:243-246 (1985)
Agurell et al., "Pharmacokinetics and Metabolism of Ɗ1 -Tetrahydrocannabinol and Other Cannabinoids with Emphasis on Man*," Pharmacological Reviews, 38(1):21-43 (1986)
Karler et al., "Different Cannabinoids Exhibit Different Pharmacological and Toxicological Properties,"NIDA Res. Monogr., 79:96-107 (1987)
Samara et al., "Pharmacokinetics of Cannabidiol in Dogs," Drug Metabolism and Disposition, 16(3):469-472 (1988)
Choi, "Glutamate Neurotoxicity and Diseases of the Nervous System," Neuron, Cell Press, 1:623-634 (1988)
Eshhar et al., "Neuroprotective and Antioxidant Activities of HU-211, A Novel NMDA Receptor Antagonist," European Journal of Pharmacology, 283:19-29 (1995)
Skaper et al., "The ALIAmide Palmitoylethanolamide and Cannabinoids, but not Anandamide, are Protective in a Delayed Postglutamate Paradigm of Excitotoxic Death in Cerebellar Granule Neurons," Neurobiology, Proc. Natl. Acad. Sci. USA, 93:3984-3989 (1996)
Alonso et al., "Simple Synthesis of 5-Substituted Resorcinols: A Revisited Family of Interesting Bioactive Molecules," J. Org. Chem., American Chemical Society, 62(2):417-421 (1997)
Combes et al. "A Simple Synthesis of the Natural 2,5-Dialkylresorcinol Free Radical Scavenger Antioxidant: Resorstation," Synthetic Communications, Marcel Dekker, Inc., 27(21):3769-3778 (1997)
Shohami et al., "Oxidative Stress in Closed-Head Injury: Brain Antioxidant Capacity as an Indicator of Functional Outcome," Journal of Cerebral Blood Flow and Metabolism, Lippincott-Raven Publishers, 17(10):1007-1019 (1997)
Zurier et al., "Dimethylheptyl-THC-11 OIC Acid," Arthritis & Rheumatism, 41(1):163-170 (1998)
Hampson et al., "Dual Effects of Anandamide on NMDA Receptor-Mediated Responses and Neurotransmission," Journal of Neurochemistry, Lippincott-Raven Publishers, 70(2):671-676 (1998)
Hampson et al., "Cannabidiol and (-)Ɗ9 -tetrahydrocannabiono are Neuroprotective Antioxidants," Medical Sciences, Proc. Natl. Acad. Sci. USA, 8268-8273 (1998)
